Search tool

Displaying 1 - 5 of 5

EMCDDA welcomes European Commission call for stronger EU action on new drugs

The EU drugs agency (EMCDDA) welcomes the European Commission's proposal today to strengthen the EU’s response to new psychoactive substances (‘new drugs’)(1). The proposal follows an unprecedented rise in the number of...

Over 100 specialists from across the globe to review international developments in new drugs field

Leading European and international specialists will meet in Lisbon from 27–28 June to take stock of the global new drugs phenomenon. The Third international multidisciplinary forum on new drugs, organised by the...

New drugs cause fundamental shift in Europe’s drug market

The number, type and availability of new drugs in Europe continued to increase in 2012, according to a report released today by the EMCDDA and Europol (1). Driven by globalisation, technological advancement...

Meeting on the risk assessment of the new psychoactive substance 5-IT

The extended Scientific Committee of the EMCDDA met on 11 April 2013 to examine the risk assessment by the EMCDDA on 5-(2-Aminopropyl)indole (5-IT).

EMCDDA expert meeting

New drug 4-MA to be placed under control across the EU

Europe has responded today to concerns over the use of the stimulant drug 4-methylamphetamine (4-MA) by subjecting it to ‘control measures and criminal penalties’ throughout the Union. The Decision of the Council...